1. High-throughput imaging of mRNA at the single-cell level in human primary immune cells
- Author
-
Carcamo A, Zonghui Hu, Alessi H, Iain D. C. Fraser, Manasi Gadkari, Luis M. Franco, Gianluca Pegoraro, and Jing Sun
- Subjects
Messenger RNA ,Cell ,Reproducibility of Results ,High throughput imaging ,Genomics ,Biology ,Cellular level ,Stimulus (physiology) ,Cell biology ,Immune system ,medicine.anatomical_structure ,Gene Expression Regulation ,Gene expression ,Transcriptional regulation ,medicine ,Humans ,RNA, Messenger ,Molecular Biology - Abstract
Measurement of gene expression at the single-cell level has led to important advances in the study of transcriptional regulation programs in healthy and disease states. In particular, single-cell gene expression approaches have shed light on the high level of transcriptional heterogeneity of individual cells, both at baseline and in response to experimental or environmental perturbations. We have developed a method for High-Content Imaging (HCI)-based quantification of transcript abundance at the single-cell level in primary human immune cells and have validated its performance under multiple experimental conditions to demonstrate its general applicability. This method, which we abbreviate as hcHCR, combines the high sensitivity of the hybridization chain reaction (HCR) for the visualization of mRNA molecules in single cells, with the speed, scalability, and technical reproducibility of HCI. We first tested eight microscopy-compatible attachment substrates for short-term culture of primary human B cells, T cells, monocytes, or neutrophils. We then miniaturized HCR in a 384-well format and documented the ability of the method to detect increased or decreased transcript abundance at the single-cell level in thousands of cells for each experimental condition by HCI. Furthermore, we demonstrated the feasibility of multiplexing gene expression measurements by simultaneously assaying the abundance of two transcripts per cell, both at baseline and in response to an experimental stimulus. Finally, we tested the robustness of the assay to technical and biological variation. We anticipate that hcHCR will be a suitable and cost-effective assay for low- to medium-throughput chemical, genetic or functional genomic screens in primary human cells, with the possibility of performing personalized screens or screens on cells obtained from patients with a specific disease.
- Published
- 2022